Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).

Sherry-Ann N Brown, Hayan Jouni, Tariq S Marroush, Iftikhar J Kullo
{"title":"Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).","authors":"Sherry-Ann N Brown,&nbsp;Hayan Jouni,&nbsp;Tariq S Marroush,&nbsp;Iftikhar J Kullo","doi":"10.1161/CIRCGENETICS.116.001613","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Whether disclosing genetic risk for coronary heart disease (CHD) to individuals influences information seeking and information sharing is not known. We hypothesized that disclosing genetic risk for CHD to individuals influences information seeking and sharing.</p><p><strong>Methods and results: </strong>The MI-GENES study (Myocardial Infarction Genes) randomized participants (n=203) aged 45 to 65 years who were at intermediate CHD risk based on conventional risk factors and not on statins to receive their conventional risk score alone or also a genetic risk score based on 28 variants. CHD risk was disclosed by a genetic counselor and then discussed with a physician. Surveys assessing information seeking were completed before and after risk disclosure. Information sharing was assessed post-disclosure. Six-month post-disclosure, genetic risk score participants were more likely than conventional risk score participants to visit a website to learn about CHD (odds ratio [OR], 4.88 [confidence interval (CI), 1.55-19.13]; <i>P</i>=0.01), use the internet for information about how genetic factors affect CHD risk (OR, 2.11 [CI, 1.03-4.47]; <i>P</i>=0.04), access their CHD risk via a patient portal (OR, 2.99 [CI, 1.35-7.04]; <i>P</i>=0.01), and discuss their CHD risk with others (OR, 3.13 [CI, 1.41-7.47]; <i>P</i>=0.01), particularly their siblings (OR, 1.92 [CI, 1.06-3.51]; <i>P</i>=0.03), extended family (OR, 3.8 [CI, 1.37-12.38]; <i>P=</i>0.01), coworkers (OR, 2.42 [CI, 1.09-5.76]; <i>P</i>=0.03), and primary care provider (PCP; OR, 2.00 [CI, 1.08-3.75]; <i>P</i>=0.03).</p><p><strong>Conclusions: </strong>Disclosure of a genetic risk score for CHD increased information seeking and sharing.</p><p><strong>Clinical trial registration: </strong>URL: https://clinicaltrials.gov/. Unique identifier: NCT01936675.</p>","PeriodicalId":10277,"journal":{"name":"Circulation: Cardiovascular Genetics","volume":"10 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.116.001613","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.116.001613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 22

Abstract

Background: Whether disclosing genetic risk for coronary heart disease (CHD) to individuals influences information seeking and information sharing is not known. We hypothesized that disclosing genetic risk for CHD to individuals influences information seeking and sharing.

Methods and results: The MI-GENES study (Myocardial Infarction Genes) randomized participants (n=203) aged 45 to 65 years who were at intermediate CHD risk based on conventional risk factors and not on statins to receive their conventional risk score alone or also a genetic risk score based on 28 variants. CHD risk was disclosed by a genetic counselor and then discussed with a physician. Surveys assessing information seeking were completed before and after risk disclosure. Information sharing was assessed post-disclosure. Six-month post-disclosure, genetic risk score participants were more likely than conventional risk score participants to visit a website to learn about CHD (odds ratio [OR], 4.88 [confidence interval (CI), 1.55-19.13]; P=0.01), use the internet for information about how genetic factors affect CHD risk (OR, 2.11 [CI, 1.03-4.47]; P=0.04), access their CHD risk via a patient portal (OR, 2.99 [CI, 1.35-7.04]; P=0.01), and discuss their CHD risk with others (OR, 3.13 [CI, 1.41-7.47]; P=0.01), particularly their siblings (OR, 1.92 [CI, 1.06-3.51]; P=0.03), extended family (OR, 3.8 [CI, 1.37-12.38]; P=0.01), coworkers (OR, 2.42 [CI, 1.09-5.76]; P=0.03), and primary care provider (PCP; OR, 2.00 [CI, 1.08-3.75]; P=0.03).

Conclusions: Disclosure of a genetic risk score for CHD increased information seeking and sharing.

Clinical trial registration: URL: https://clinicaltrials.gov/. Unique identifier: NCT01936675.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冠心病遗传风险披露对信息寻求和共享的影响:心肌梗死基因的MI-GENES研究。
背景:向个体披露冠心病遗传风险是否会影响信息寻求和信息共享尚不清楚。我们假设向个人披露冠心病的遗传风险会影响信息的寻找和共享。方法和结果:MI-GENES研究(心肌梗死基因)将年龄在45至65岁、基于常规危险因素且未使用他汀类药物的中度冠心病风险的参与者(n=203)随机分组,单独接受常规风险评分或基于28种变异的遗传风险评分。由遗传咨询师披露冠心病风险,然后与医生讨论。评估信息寻求的调查在风险披露之前和之后完成。信息共享在披露后进行评估。6个月后,遗传风险评分参与者比常规风险评分参与者更有可能访问网站了解冠心病(优势比[OR], 4.88[置信区间(CI), 1.55-19.13];P=0.01),使用互联网获取遗传因素如何影响冠心病风险的信息(OR, 2.11 [CI, 1.03-4.47];P=0.04),通过患者门户了解其冠心病风险(OR, 2.99 [CI, 1.35-7.04];P=0.01),并与其他人讨论其冠心病风险(OR, 3.13 [CI, 1.41-7.47];P=0.01),尤其是其兄弟姐妹(OR, 1.92 [CI, 1.06-3.51];P=0.03),大家庭(OR, 3.8 [CI, 1.37-12.38];P=0.01),同事(OR, 2.42 [CI, 1.09-5.76];P=0.03),初级保健提供者(PCP;Or为2.00 [ci, 1.08-3.75];P = 0.03)。结论:冠心病遗传风险评分的披露增加了信息的寻求和共享。临床试验注册:网址:https://clinicaltrials.gov/。唯一标识符:NCT01936675。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Circulation: Cardiovascular Genetics
Circulation: Cardiovascular Genetics CARDIAC & CARDIOVASCULAR SYSTEMS-GENETICS & HEREDITY
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.
期刊最新文献
Genome-Wide Gene-Potassium Interaction Analyses on Blood Pressure: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity). Genetic Variants Contributing to Circulating Matrix Metalloproteinase 8 Levels and Their Association With Cardiovascular Diseases: A Genome-Wide Analysis. Genetic Testing in Pediatric Left Ventricular Noncompaction. Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy. FLNC (Filamin-C): A New(er) Player in the Field of Genetic Cardiomyopathies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1